Insider Analysis From Heller Ehrman LLP: How China’s Courts Determine Damages in Patent Infringement Cases
This article was originally published in PharmAsia News
Executive Summary
By Jason Ma, Heller Ehrman, San Francisco/Hong Kong and Michael Phillips, Heller Ehrman, Hong Kon